| scholarly article | Q13442814 |
| P356 | DOI | 10.3233/JAD-150309 |
| P698 | PubMed publication ID | 26401933 |
| P50 | author | Ewa Papuć | Q116262414 |
| Marcin R Tatara | Q61126888 | ||
| Konrad Rejdak | Q91202618 | ||
| Witold Krupski | Q115726769 | ||
| P2093 | author name string | Ewa Kurys-Denis | |
| P2860 | cites work | Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease | Q27860795 |
| The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics | Q27860914 | ||
| Differential ultrastructural localization of myelin basic protein, myelin/oligodendroglial glycoprotein, and 2',3'-cyclic nucleotide 3'-phosphodiesterase in the CNS of adult rats | Q28578012 | ||
| Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination | Q29614990 | ||
| Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease | Q33782706 | ||
| Molecular pathways to neurodegeneration | Q35844771 | ||
| Immunocytochemical localization of basic protein in major dense line regions of central and peripheral myelin | Q36206980 | ||
| The myelin-associated glycoprotein is enriched in multivesicular bodies and periaxonal membranes of actively myelinating oligodendrocytes | Q36221890 | ||
| Blood-brain barrier: ageing and microvascular disease--systematic review and meta-analysis | Q36942382 | ||
| Antineuronal antibodies in Parkinson's disease | Q37126355 | ||
| The blood-brain barrier in neurodegenerative disease: a rhetorical perspective | Q37385549 | ||
| Decreased white matter integrity in late-myelinating fiber pathways in Alzheimer's disease supports retrogenesis | Q37434774 | ||
| Peptide determinants of myelin proteolipid protein (PLP) in autoimmune demyelinating disease: a review | Q40395816 | ||
| Assessing white matter ischemic damage in dementia patients by measurement of myelin proteins. | Q42132599 | ||
| Decreased inflammation and augmented expression of trophic factors correlate with MOG-induced neuroprotection of the injured nigrostriatal system in the murine MPTP model of Parkinson's disease | Q46088148 | ||
| Anti-MOG autoantibodies in Italian multiple sclerosis patients: specificity, sensitivity and clinical association | Q47897582 | ||
| Reactive microglia in aging and dementia: an immunohistochemical study of postmortem human brain tissue | Q48233669 | ||
| Focal demyelination in Alzheimer's disease and transgenic mouse models. | Q48285985 | ||
| Preferential loss of myelin-associated glycoprotein reflects hypoxia-like white matter damage in stroke and inflammatory brain diseases. | Q48409149 | ||
| Chronic cerebral hypoperfusion induces MMP-2 but not MMP-9 expression in the microglia and vascular endothelium of white matter. | Q48824436 | ||
| Alterations in the blood brain barrier in ageing cerebral cortex in relationship to Alzheimer-type pathology: a study in the MRC-CFAS population neuropathology cohort. | Q48862798 | ||
| Astrocyte phenotype in relation to Alzheimer-type pathology in the ageing brain | Q49142951 | ||
| Immunocytochemical observations on the distribution of myelin-associated glycoprotein and myelin basic protein in multiple sclerosis lesions | Q50944800 | ||
| Fibrillar amyloid deposition leads to local synaptic abnormalities and breakage of neuronal branches. | Q52560574 | ||
| Cardiovascular and other risk factors for Alzheimer's disease and vascular dementia. | Q53235124 | ||
| Vascular involvement in cognitive decline and dementia. Epidemiologic evidence from the Rotterdam Study and the Rotterdam Scan Study. | Q53235144 | ||
| Evidence for a “dying‐back” gliopathy in demyelinating disease | Q54538103 | ||
| Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study | Q59273880 | ||
| P433 | issue | 1 | |
| P921 | main subject | Alzheimer's disease | Q11081 |
| biomarker | Q864574 | ||
| P304 | page(s) | 115-121 | |
| P577 | publication date | 2015-01-01 | |
| P1433 | published in | Journal of Alzheimer's Disease | Q6294755 |
| P1476 | title | Can Antibodies Against Glial Derived Antigens be Early Biomarkers of Hippocampal Demyelination and Memory Loss in Alzheimer's Disease? | |
| P478 | volume | 48 |
| Q92538007 | Anti-Myelin Proteolipid Protein Peptide Monoclonal Antibodies Recognize Cell Surface Proteins on Developing Neurons and Inhibit Their Differentiation |
| Q38705852 | Autoantibodies against myelin sheath and S100β are associated with cognitive dysfunction in patients with rheumatoid arthritis. |
| Q60962004 | Bojungikgi-Tang, a Traditional Herbal Formula, Exerts Neuroprotective Effects and Ameliorates Memory Impairments in Alzheimer's Disease-Like Experimental Models |
| Q55383962 | Citrullination as a plausible link to periodontitis, rheumatoid arthritis, atherosclerosis and Alzheimer’s disease. |
| Q58549216 | Early Life Stress and Epigenetics in Late-onset Alzheimer's Dementia: A Systematic Review |
| Q28559519 | Genes of susceptibility to early neurodegenerative changes in the rat retina and brain: analysis by means of congenic strains |
| Q51764702 | Lipopolysaccharide Associates with Amyloid Plaques, Neurons and Oligodendrocytes in Alzheimer's Disease Brain: A Review. |
| Q37327404 | Myelin injury induces axonal transport impairment but not AD-like pathology in the hippocampus of cuprizone-fed mice |
| Q38814687 | Remyelination: A Potential Therapeutic Strategy for Alzheimer's Disease? |
| Q90447268 | The role of myelin damage in Alzheimer's disease pathology |
| Q92924571 | White Matter and Neuroprotection in Alzheimer's Dementia |
Search more.